IL195590A0 - Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands - Google Patents

Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands

Info

Publication number
IL195590A0
IL195590A0 IL195590A IL19559008A IL195590A0 IL 195590 A0 IL195590 A0 IL 195590A0 IL 195590 A IL195590 A IL 195590A IL 19559008 A IL19559008 A IL 19559008A IL 195590 A0 IL195590 A0 IL 195590A0
Authority
IL
Israel
Prior art keywords
hydroxytrytamine
benzoxazole
ligands
benzothiazole derivatives
benzothiazole
Prior art date
Application number
IL195590A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of IL195590A0 publication Critical patent/IL195590A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL195590A 2006-06-01 2008-11-27 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands IL195590A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80999606P 2006-06-01 2006-06-01
PCT/US2007/012569 WO2007142904A2 (en) 2006-06-01 2007-05-25 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands

Publications (1)

Publication Number Publication Date
IL195590A0 true IL195590A0 (en) 2009-09-01

Family

ID=38668755

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195590A IL195590A0 (en) 2006-06-01 2008-11-27 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands

Country Status (17)

Country Link
US (1) US7501421B2 (enExample)
EP (1) EP2024348A2 (enExample)
JP (1) JP2009538909A (enExample)
KR (1) KR20090023641A (enExample)
CN (1) CN101490022A (enExample)
AR (1) AR061147A1 (enExample)
AU (1) AU2007255041A1 (enExample)
BR (1) BRPI0712444A2 (enExample)
CA (1) CA2659701A1 (enExample)
CR (1) CR10474A (enExample)
EC (1) ECSP088930A (enExample)
IL (1) IL195590A0 (enExample)
MX (1) MX2008015328A (enExample)
NO (1) NO20085045L (enExample)
PE (1) PE20080707A1 (enExample)
TW (1) TW200804310A (enExample)
WO (1) WO2007142904A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2414328B1 (en) * 2009-04-02 2021-05-26 Merck Serono S.A. Dihydroorotate dehydrogenase inhibitors
KR101250606B1 (ko) * 2011-01-24 2013-04-03 이화여자대학교 산학협력단 5-ｈｔ６ 수용체 억제 작용을 갖는 신규한 벤조티아졸 및 벤즈이소티아졸유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물
JP6345664B2 (ja) * 2013-07-10 2018-06-20 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 新規ｐｄｅ４阻害剤
EP3166924B1 (en) 2014-07-08 2019-02-20 Sunshine Lake Pharma Co., Ltd. Aromatic heterocyclic derivatives and pharmaceutical applications thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582635B2 (en) 2002-12-24 2009-09-01 Purdue Pharma, L.P. Therapeutic agents useful for treating pain
GB0422263D0 (en) * 2004-10-07 2004-11-10 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
US20070281945A1 (en) 2007-12-06
AU2007255041A1 (en) 2007-12-13
CN101490022A (zh) 2009-07-22
NO20085045L (no) 2008-12-12
WO2007142904A3 (en) 2008-02-07
MX2008015328A (es) 2008-12-12
AR061147A1 (es) 2008-08-06
US7501421B2 (en) 2009-03-10
WO2007142904A2 (en) 2007-12-13
EP2024348A2 (en) 2009-02-18
CR10474A (es) 2009-01-07
TW200804310A (en) 2008-01-16
PE20080707A1 (es) 2008-05-22
ECSP088930A (es) 2009-01-30
JP2009538909A (ja) 2009-11-12
BRPI0712444A2 (pt) 2012-06-05
KR20090023641A (ko) 2009-03-05
CA2659701A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
ZA201004689B (en) Benzothiazole and benzoxazole derivatives and methods of use
IL189627A0 (en) Thiazole derivatives
IL199892A0 (en) Thiazolidine derivatives and methods for the preparation thereof
IL195007A0 (en) Thiazole derivatives
IL194368A0 (en) Thiazole compounds as cannabinoid receptor ligands and uses thereof
IL192634A0 (en) Thiazoles as 11 beta-hsd1 inhibitors
IL220270A0 (en) Polymyxin derivatives and uses thereof
IL197693A0 (en) Phenyl derivatives and their use as immunomodulators
ZA200806075B (en) Novel heteroaryl substituted benzothiazoles
EP2193127A4 (en) BENZOTHIAZOLE COMPOUNDS
IL205751A0 (en) Aminothiazole derivatives
GB0812031D0 (en) Thiazole derivatives
IL204563A0 (en) Thiazole derivatives
IL188398A0 (en) Thiazoles derivatives as ampk activator
IL198301A0 (en) Thiazole and oxazole-substituted arylamides
IL188857A0 (en) Novel benzothiazolone derivatives
EP2131656A4 (en) phthalazine
ZA200806870B (en) Casing and fluid machine
PL2220060T3 (pl) Pochodne tetrahydrobenzotiazolu
IL194880A0 (en) Aminothiazole derivatives and their uses as antibacterial agents
GB0718999D0 (en) Merocyanine derivatives
EP1894930A4 (en) THIAZOLE DERIVATIVE
ZA200710104B (en) Thiazole derivatives and use thereof
IL195590A0 (en) Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands
EP2068903A4 (en) S-NITROSOTHIOL COMPOUNDS AND RELATED DERIVATIVES